About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 985 record(s)
Req # A-2023-000161
Adverse Drug Reactions (ADRs) for TEMODAL. Report numbers: E2B_03072550, E2B_02069473, E2B_02600423, E2B_02839770, E2B_03200196.Organization: Health Canada
July 2023
June 2023
June 2023
Req # A-2023-00011
Rose Acquisition Corporation (the “Purchaser”) purchase from General Electric Canada Property Inc. (the “Vendor”) PT LT 12, CON 3 TRAF SDS, AS IN TW14350 EXCEPT PT 1 PE227; LTS 113 & 114, PLAN 1009. T/W TW21034.; TOWN OF OAKVILLE; being all of PIN 24806-0373 (LT) 420 South Service Road East, Oakville, Ontario L6J 2X6 (the “Property”) Closing Date: As soon as possible Our File No.: 12652-007Organization: Canadian Nuclear Safety Commission
June 2023
Req # A-2023-00016
The minutes of the CNSC’s Management Committee for April 2023.Organization: Canadian Nuclear Safety Commission
June 2023
Req # A-2022-001575
Written policies and procedures of Health Canada Exemptions section for dealing with Exemption Applications under subsection 56(1) exemption as it pertains to religious exemptions.Organization: Health Canada
June 2023
Req # A-2022-001437
Adverse Drug Reaction (ADR). Report number: E2B_05891872.Organization: Health Canada
June 2023
Req # A-2023-000081
Adverse Drug Reactions (ADRs). Report numbers: E2B_06195463, E2B_06198287.Organization: Health Canada
June 2023
Req # A-2023-000316
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-101815-520, Exceptions for the Information Technology Community.Organization: Health Canada
June 2023
Req # A-2023-00008
The minutes of the CNSC’s Management Committee for March 2023.Organization: Canadian Nuclear Safety Commission
May 2023